Tisch Cancer Institute at Mount Sinai — New York, New York

Tisch Cancer Institute at Mount Sinai is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

Tisch Cancer Institute at Mount Sinai has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Extensive Stage Small Cell Lung Cancer, Relapsed or Refractory Multiple Myeloma.

Sponsors: STCube, Inc., ModernaTX, Inc..

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tisch Cancer Institute at Mount Sinai?

Tisch Cancer Institute at Mount Sinai has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tisch Cancer Institute at Mount Sinai conducted?

Tisch Cancer Institute at Mount Sinai has 2 clinical trials on record, with 1 currently active. Their work covers Extensive Stage Small Cell Lung Cancer, Relapsed or Refractory Multiple Myeloma.

Is Tisch Cancer Institute at Mount Sinai accredited by Crixeo Health?

Tisch Cancer Institute at Mount Sinai has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Tisch Cancer Institute at Mount Sinai?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.